Attention needs more attention
Illustration by Chris Kindred

Forefront

Attention needs more attention

Illustration by Chris Kindred

Life can sometimes feel overwhelming—and it literally is. Every second, a tremendous soup of sensory information floods our minds: sights, sounds, and sensations, all clamoring to be known. If it weren’t for the brain’s capacity for selective attention, the world would forever look like chaos.

Selective attention allows your brain to decide which sensory input to prioritize at any given moment (as you’re reading these words, for example, it’s giving premium processing status to the sight of letters). It’s an essential task whose biological machinery resides in a handful of areas, all confined to the brain’s parietal and frontal lobes—or so scientists have long thought.

A few months ago, however, two neuroscientists reported on their discovery of a new area that appears to control selective attention. In their behavioral experiments, in which subjects were tasked with watching moving dots on a screen, this unheard-of area kept lighting up. Further tests revealed its neurons closely track precisely which part of the screen is being attending to—the signature characteristic of an attention-governing brain region.

The discovery has also introduced new mysteries. For one thing, the new area is located in an unlikely place—the dorsal part of the posterior inferotemporal cortex—outside of where scientists would normally expect to find attention governing circuits. That’s a sign that the classical account of selective attention isn’t the full story, says Rockefeller professor Winrich Freiwald, who published the findings in the Proceedings of the National Academy of Sciences together with a colleague at the University of Bremen.

“Scientists may have to fundamentally rethink how some aspects of our brains are organized,” Freiwald says.

This fish is about to flip

Forefront

This fish is about to flip

It’s not pleasant to swim when the pool is too hot.

In the lab of Alipasha Vaziri, a gang of zebrafish larvae has found an elegant solution to this problem: by simply flipping their tails to one side, they can cool down the water around them. The direction is important—every once in a while, the fish will try flipping the other way. It never helps.

Outside the fish tank, researchers are monitoring each tail flip and simultaneously detecting the activity of neurons in the animals’ brains. Unbeknownst to the fish, these humans are guilty of warming the water in the first place, with lasers, and of letting it cool to reward fishes that have learned the correct way to flip. In repeating this drill, they’ve been teaching the fish a new, goal-oriented behavior. It’s part of an intricate experimental setup, designed to shed light on one of neuroscience’s greatest enigmas: How brains make decisions.

Once a fish has mastered the new trick, it responds to rising temperature by flipping its tail—and in eight times out of ten, it moves in the correct direction. The whole episode takes about 20 seconds, but the scientists are honing in on a shorter interval right after the water-warming laser is switched on and before the fish moves—the key moment when the “left or right?” choice is made.

“The goal is to understand how decisions unfold,” says Vaziri.

10M

Data

The number of neurons in an adult zebrafish. Cats have about 25 times as many, lobsters 100 times less.

In a recent paper in Cell, the scientists described the activity state of about 5,000 neurons across the entire fish brain. They identified a number of activity patterns—some related to the brain’s sensing the heat, some to its coordinating tail flips, and others to the decision making process. They also found that, about 10 seconds before a fish moves, those patterns will foreshadow whether it’s about to make the correct or incorrect turn.

In fact, just by observing the brain-activity profiles, the scientists could usually guess beforehand when the fish would move its tail, and whether it would gear left or right.

If predicting an animal’s next move seems remarkable, so is the technology the scientists developed in order to conduct these experiments. Tracking how neurons across multiple brain regions respond and cooperate is anything but trivial, and Vaziri’s team made it possible by pairing advanced statistical methods with a novel light-field microscopy technique, also developed in the lab.

We need to get better at making vaccines—for more reasons than COVID-19
Activated B cells cluster in germinal centers (blue, green, and purple) inside a mouse lymph node. The Rockefeller University / Laboratory of Lymphocyte Dynamics

Forefront

We need to get better at making vaccines—for more reasons than COVID-19

Activated B cells cluster in germinal centers (blue, green, and purple) inside a mouse lymph node. The Rockefeller University / Laboratory of Lymphocyte Dynamics

New pandemics require new vaccines; some old plagues require better ones. For example, scientists have tried for decades to develop a universal flu vaccine that works for every version of the virus, but this goal remains elusive. Last year, influenza killed more than 60,000 Americans.

But new opportunities are on the horizon—and according to Gabriel D. Victora, the Laurie and Peter Grauer Assistant professor, some might come from learning how antibody-producing B cells move in and out of germinal centers. Located in lymph nodes, germinal centers are what Victora calls “boot camps” for activated B cells. “The cells go in as amateurs, and come out as skilled professionals making antibodies that bind more tightly to their targets,” he says.

In recent work published in Cell, Victora’s team found that those educated B cells don’t easily return to camp the second time they’re exposed to an invader—which might make it hard to develop effective vaccines against highly variable viruses. “If we can find the bottlenecks, and learn how to circumvent them, that might lead to improved vaccination strategies,” he says.

The implications may extend to viruses other than the flu, like HIV and hepatitis C—and perhaps also to coronaviruses.

Return of the cytonaut
Illustration by Wenkai Mao

Forefront

Return of the cytonaut

Illustration by Wenkai Mao

“Cells live in a watery world, even when the organisms of which they are part do not,” wrote Christian de Duve in his 1984 book, A guided tour of the living cell. Most human cells, for instance, are immersed in fluids that render their vast inner space jelly like. Floating within this cytoplasmic soup are mitochondria, ribosomes, vacuoles, and many other so-called organelles—tiny instruments that carry out a cell’s basic functions.

Inspired by the films of Jacques Cousteau, de Duve wanted his readers to embark on the journey with the mindset of a “cytonaut” ready to explore “a strange world, fascinating, mysterious, but very far removed from our everyday experience.” The late cell biologist was himself a pioneer who, together with Albert Claude and George E. Palade, spent the 1940s and 50s detailing the first functional map of the cell—work for which the three Rockefeller scientists later shared a Nobel Prize.

A must-see along the tour is the lysosome, a bubble-shaped organelle that de Duve was the first to set eyes on in 1955, and whose acidic interior was subsequently found to serve various purposes, like breaking down cellular debris. Yet it wasn’t until early this year that scientists discovered that our cells need this sour little sac to process iron, an essential nutrient, into a form they can metabolize in order to survive. This may in fact be the most important of the lysosome’s functions.

Graduate student Ross Weber made the discovery in a lab not far from the one de Duve once inhabited. There, he manipulated cells to make their lysosomes less acidic, in an experiment that had to be controlled with minute precision. For reasons that have long been unknown, cells will stop dividing and die if the pH within lysosomes raises above a certain threshold.

Today Weber and other members of the lab, led by Kivanç Birsoy, have a possible explanation for this phenomenon: Their experiments showed that cells with more-alkaline lysosomes suffer iron depletion—and as a result, they lose their ability to produce essential molecules like DNA. “Lysosomes participate in a lot of different cell functions like signaling, metabolism and recycling,” says Birsoy, who is Rockefeller’s Chapman Perelman Assistant Professor, “but processing iron seems to be the only thing cells really cannot do without them.”

He hopes the new research, published in Molecular Cell, might lead to the development of novel cancer therapies. Several types of tumors cells are known to be sensitive to elevated lysosome pH, and the new findings suggest it’s the ensuing iron deficiency that brings these tumor cells the fatal blow. This could mean that depleting tumors of iron offers an effective way to kill them, says Birsoy, and is the latest possibility to come out of his lab’s extensive effort to develop new treatments that starve tumors for nutrients they cannot produce on their own.

The team also plans to find out whether the new findings could be relevant to other conditions linked to the loss of lysosome acidity, including a group of rare metabolic disorders and neurodegenerative diseases. “We believe there are a lot of exciting possibilities out there,” Birsoy says.

Moreover, the lysosome isn’t the only organelle whose inner secrets might yield ideas for new medicines. Mitochondria, for example, the cell’s peanut-shaped powerhouses, are the targets of several promising cancer treatments. And who knows what other treasures may await 21st century cytonauts as they plunge deeper down the cellular sea.

A ride out of the pandemic?
For years, Rocky and Marley have participated in research aimed at harnessing the wonders of their immune system. The llamas live in pastures in rural Massachusetts. Photograph by Capralogics

Forefront

A ride out of the pandemic?

For years, Rocky and Marley have participated in research aimed at harnessing the wonders of their immune system. The llamas live in pastures in rural Massachusetts. Photograph by Capralogics

“It seems very strange that we should be picking, of all things, llamas,” says Michael P. Rout, referring to his latest project with Brain T. Chait, the Camille and Henry Dreyfus Professor. “But for reasons we don’t really understand, llamas make antibodies with fantastic properties.”

Llama antibodies are smaller—but no less potent—than those humans make, and they are easy and cheap to mass-produce. The two scientists—with help from their two llamas—are using them to develop COVID-19 treatments for extra-widespread use, enough to help an ailing planet.

Watch this video to learn more.

Multilingual moves
Anna Erzberger and James A. Hudspeth inspecting their fish tanks. Photograph by Mario Morgado

Forefront

Multilingual moves

Anna Erzberger and James A. Hudspeth inspecting their fish tanks. Photograph by Mario Morgado

When embryonic structures take shape, their cells must navigate with painstaking choreography. One wrong step, and the whole tissue may warp. The hair cells of the inner ear, the sensory organ used for hearing and balance, are a striking example: They neatly line up in two rows facing each other, like cadets during a formation.

“The cells have no blueprint for where to go, they just figure it out themselves by talking to each other,” says postdoctoral fellow Anna Erzberger. It sounds simple, but it’s not.

Together with colleagues in the group of A. James Hudspeth, the F. M. Kirby Professor, Erzberger has studied the developmental process that plays out in the fish equivalent of an inner ear. As it turns out, immature hair cells use more than one language to communicate.

When one cell divides into two, the daughters first in engage in biochemical signaling—long held to be the singular mode of cellular discourse—to establish their individual identities. But soon after, they switch to mechanical lingo, enabling a kind of course correction. At this stage, the two cells may randomly find themselves occupying either the “right” or the “wrong” spot relative to one another—and in the latter case, they swap places. Propelled by surface-tension forces, the two cells gingerly dance past each other to assume the correct orientation.

“Traditionally, scientists have looked only to changes in genes and proteins to explain how developmental events happen,” says Erzberger, who co-authored a paper on the findings published in Nature Physics in May. “But biochemistry is only part of the story, and the missing link is often mechanics.”

What Darwin never guessed
Contemporary turtle ant soldiers display a wide range of head shapes and sizes, with a several-fold difference between the smallest and the largest heads. Photograph by Scott Powell

Forefront

What Darwin never guessed

Contemporary turtle ant soldiers display a wide range of head shapes and sizes, with a several-fold difference between the smallest and the largest heads. Photograph by Scott Powell

The origin of species usually goes like this: One group of stickleback fish live at sea, the other goes to freshwater, and voila—the species splits into two. So for centuries, evolution has been thought to generally march in the same direction, toward new traits and more-specialized adaptations. But recently, scientists at Rockefeller and George Washington University found a quirky exception.

Turtle ants live in trees, in tunnels pre-excavated by beetles. To keep intruders out, ant soldiers use their large heads to plug the tunnels. But when an ant colony moves to a new habitat the soldiers may have to adapt to larger or smaller holes dug by a different beetle species, and the size and shape of their heads evolves for a snug fit. Surprisingly, researchers found that this aspect of ant evolution has gone both forwards and backwards—sometimes creating novel head shapes, other times reverting to more primitive ones.

“You would think that once a species is specialized, it’s stuck in that narrow niche,” says Daniel Kronauer, the Stanley S. and Sydney R. Shuman Associate Professor, whose team published the findings in the Proceedings of the National Academy of Sciences. “But turtle ants have a very dynamic evolutionary trajectory with a lot of back and forth.”

When zombies take over the brain
Illustration by Tiahua Mao

Forefront

When zombies take over the brain

Illustration by Tiahua Mao

Death is a complex affair, at least for cells. There are several ways in which a cell can die: It might commit a form of suicide known as apoptosis, for example, or suffocate to death by necrosis. Further complicating matters is the fact that some cells that appear dead as rocks are in fact in a limbo between life and death—a state from which they might at some point return as transformed versions of their old selves.

An intriguing example of such cellular zombies was recently discovered in the lab of Paul Greengard, a Nobel Laureate and Rockefeller’s Vincent Astor Professor who passed away last year. It happened when a team of scientists were trying to figure out what goes wrong in the brains of people with Parkinson’s disease. The researchers had long struggled to understand why dopamine-producing neurons in the midbrain perish, leading to debilitating movement problems characteristic of Parkison’s.

In retrospect, they may have been asking the wrong question. As the scientists reported in Cell Stem Cell, at least some of these midbrain neurons appear not to be dead after all, but to rather be resting in the zombie-like state, known as senescence. And the results suggest that a zombie neuron may be even more damaging to the central nervous system than a dead one: By releasing inflammatory chemicals, the undead cells spread senescence to surrounding healthy neurons and make those neighbors shut down as well.

Research associate Markus Riessland says the discovery was especially surprising given that senescence is almost unheard of among neurons, although it does occur quite frequently in other parts of the body.

“Our findings shed new light on how the disease progresses,” he says “and might provide new opportunities for treatment.” For example, Riessland and his colleagues suspect that so-called senolytic drugs, which are known to remove senescent cells, might make it possible to slow the brain’s deterioration in Parkinson’s patients.

Experiences, memories, and the elusive element of time
Illustration by Iker Ayestaran

Forefront

Experiences, memories, and the elusive element of time

Illustration by Iker Ayestaran

The way we act and react is often informed by our past—specifically, by good or bad experiences that help us project what may transpire in the future. A classic example is the Russian psychologist who rang a bell before feeding his dog—eventually the dog learned to salivate at the sound even in the absence of dinner.

But Pavlov’s story tends to glaze over an important factor in this behavioral equation. Today’s neuroscientists have reasons to suspect that associative learning isn’t merely the outcome of a cue being linked to a reward—the order of these events matters, too.

Consider a scenario where the bell normally rings after, not before, the arrival of dog biscuits. To the canine diner, the sound won’t then represent bliss, but the end of bliss; and it will presumably produce memories of sadness rather than of appetite. All of which suggests that the brain doesn’t just file experiences of different kinds in its memory bank—it somehow assigns time stamps to these experiences as well.

Time is a weird thing from a biological perspective, far more abstract than sounds or objects. You can’t see, hear, touch, or taste it, yet the brain seems quite capable of tracking it. Precisely how this chronicling occurs in the context of learning is something that researchers in the lab of Vanessa Ruta, the Gabrielle H. Reem and Herbert J. Kayden Associate Professor, are very keen to understand.

The lab doesn’t have much faith in the dog as a model system, however. For these scientists, man’s best friend is Drosophila melanogaster, the humble fruit fly. Recently, Ruta’s team set up a modern version of Pavlov’s experiment in which they exposed flies to an odor rather than to a sound; and instead of rewarding the animals with a treat, they used optogenetic technology to directly stimulate reward-signaling neurons in the flies’ brains.

The results were clear. When the flies were given a reward signal immediately after receiving a puff of the smell, they became attracted to that scent; but when the reward came before the smell, they shunned it instead. “The difference in time is only one or two seconds, yet the flies form completely opposing associations,” says graduate fellow Annie Handler.

She and her colleagues identified a set of brain cells whose activation enables the fly to know the sequence of events. In addition, they found that flies that had learned to covet the smell could quickly be retrained to detest it, and vice versa. In other words, flies are like us in that their memories are not set in stone.

“There are so many things that we could remember on a daily basis, so we hold on to the memories that turn out to be predictive; and we toss out associations that are incorrect or irrelevant,” says Ruta. “When you live in a dynamic environment—which both flies and humans do—that seems like a very good strategy.”

A historic touch

On Campus

A historic touch

Several decades of science were conducted in Rockefeller’s Smith and Flexner Halls before their interiors were gutted in a 2010 renovation. A new interactive installation, the Scientist Explorer, honors the 137 men and women with labs in the buildings—from the first who arrived in 1917 to those currently on the faculty. Occupants and visitors of today’s Collaborative Research Center, which connects the two buildings, can use the circular touchscreen to explore the work of both neighbors and predecessors.

Spermatic innovators
Photograph by Mario Morgado

Forefront

Spermatic innovators

Photograph by Mario Morgado

Sperm science has a curious past, supported at times less by fact than by the (predominantly male) imagination. In the late 17th century, when Dutch scientists caught the first glimpse of the tadpole-like cells under the microscope, they decided that each one carried within its head a miniature human being that would grow into a baby—positing that the egg cell, discovered decades earlier, played but a minor role in human reproduction.

This myth was eventually debunked, but others followed, including the still-popular idea that ejaculated spermatocytes purposefully swim toward the egg, propelled by an ancient drive to outcompete sperm from other males. In reality, these cells are much less heroic: They don’t even swim very far but passively drift across the uterus, buoyed along by soft motions in the female tissue.

In short, we have yet to see the evidence of machismo manifesting at the micro scale.

This isn’t to say sperm are completely without agency, however. They do have at least one impressive talent: an unsurpassed knack for building novel genes. In this sense, the testes are not mere sperm factories but also laboratories churning out fresh DNA content—undeniably a seminal mission given that new genes are the raw material for the evolution of species.

Recently, scientists took a major step toward understanding how nature’s attempts at innovation play out during the development of sperm. Working with fruit flies, a team in the laboratory of Li Zhao created a detailed map of DNA mutations arising in each sperm and the activity of new genes arising from those mutations.

“It offers an unprecedented perspective on a process that enables living things to adapt and evolve, and that ultimately contributes to the diversity of life on Earth,” Zhao says about the research, published in eLife earlier this fall.

Her team is interested in so-called de novo genes that emerge from scratch rather than through duplication of existing genes. The fly sperm turned out to be a treasure trove—in it, the scientists identified 184 previously unknown de novo genes. Zhao suspects that some of these genes may play a role in spermatocytogenesis, the process in which sperm form from precursor cells. “Precisely what de novo genes are doing to move sperm development along is an exciting open question,” she says.

Fat, miscalibrated
Losing one’s leptin makes it hard to stay slim. Photograph by Zachary Veilleux

Forefront

Fat, miscalibrated

Losing one’s leptin makes it hard to stay slim. Photograph by Zachary Veilleux

Nature has its way of keeping things in balance. When it comes to body weight, the key regulator is leptin, a hormone secreted by fat cells. When fat storage increases, leptin informs the brain to lower appetite—and vice versa. That’s how the body balances its fat stores and food intake, keeping them within a fine range.

In some people, however, the system miscalculates. For the past 25 years, since leptin was first discovered by Rockefeller’s Jeffrey M. Friedman, scientists have wanted to understand exactly how changes in the hormone’s function may lead to obesity, an ever-worsening public health problem that now affects more than 650 million adults worldwide. Some have suggested that the disease is caused by problems in leptin’s faithful reporting of fat levels to the brain; others have argued that it is in fact due to the brain’s failure to respond to the hormone.

It turns out this internal calibrator can go kaput in different ways in different people.

In a study published in Nature Medicine earlier this year, Friedman, the Marilyn M. Simpson Professor, and his collaborators suggest that at least 10 percent of obese people may be genetically incapable of producing sufficient leptin at all. No matter how much fat is stored in the body, their leptin levels remain low.

“These people have less leptin from an early age, making them a little bit hungrier than everyone else,” says Olof Dallner, a research associate and the lead author of the study.

Fat, miscalibrated - scale

Data

A typical leptin-deficient mouse weighs 1.94 times more than the average lab mouse.

The researchers traced the problem to a type of RNA that seems to regulate how much leptin is produced. When the team engineered mice without this specific RNA, and fed them a high-fat diet, the mice kept accumulating fat to the point of becoming obese, but their leptin levels nevertheless remained low. Another group of unaltered mice munching on the same unhealthy diet became a little chubby, too—but this group produced normal amounts of leptin, which appears to have kept them from becoming outright obese.

There’s compelling evidence that these findings might pertain to humans, too. When the team looked at the genetic profiles of more than 46,000 people, they found that alterations in the human version of the same RNA are linked with lower leptin levels. Some people, this work suggests, may have a subtype of obesity that’s potentially treatable with leptin therapy. That was indeed the case with the low-leptin mice: When the animals received injections of leptin, they lost weight.

All of this is good news for people with leptin-curbing mutations. But most obese people gain weight not because of too little leptin but because their brain has stopped responding to it. For this group, there may be other avenues for therapy—for example, targeting the brain networks that control not just how much we eat, but also how much energy we burn.

In a recent study published in Cell, Friedman’s team identified a group of neurons in the brain stem that do just that. In mice, turning the neurons off triggers the burning of fat to produce body heat, and also decreases hunger. It suggests that these multitalented cells could be powerful levers for managing body weight—especially if they could be targeted with drugs.

Camouflaged targets
Sakmar and Lorenzen in the lab. Photograph by Mario Morgado

Forefront

Camouflaged targets

Sakmar and Lorenzen in the lab. Photograph by Mario Morgado

Nearly one-third of all medications act on the same type of molecule, called a G protein coupled receptor. In humans, there are an average of about 800 GPCRs on the surface of each cell, and it might come as a surprise that even in such a well-studied and successful family, there are still over a hundred receptors that remain a mystery. Scientists have not been able to pinpoint their precise function.

And that hasn’t been for lack of trying—with their promising pedigree, GPCRs have been the focus of intense drug discovery research. The next drug target for migraine, osteoporosis, or brain cancer could be a GPCR, if only you could find a molecule that would unlock the receptor. More often than not, it seems that nothing does.

“One hypothesis is that some component is missing,” says Thomas P. Sakmar, the Richard M. and Isabel P. Furlaud Professor.

That missing component, it turns out, could be the receptors’ little-known accessory proteins. Graduate student Emily Lorenzen, who recently developed a high-throughput technique to study GPCRs, was surprised to discover that many of these receptors may get outfitted with accessory proteins inside cells. This means that a receptor’s overall shape and function might often be different in the test tube—where the receptor is naked—than inside the body.

The findings, described in Science Advances, may explain why some drugs that show promise in the lab go on to fail in human trials. If a drug is designed to bind to a naked receptor, it might miss its target inside cells or tissues, where the receptor is camouflaged with its accessory protein. With the receptors’ double appearance revealed, researchers hope the path to drug discovery will be smoother.

Huntington’s goes way back
The Rockefeller University / Laboratory of Stem Cell Biology and Molecular Embryology

Forefront

Huntington’s goes way back

The Rockefeller University / Laboratory of Stem Cell Biology and Molecular Embryology

Most people with Huntington’s disease don’t show symptoms until age 30 or older. But a new technology has made it possible to trace the condition back to the biological events that instigate it—and those events, it turns out, happen long before birth.

The discovery is very meaningful, says Ali H. Brivanlou, who led the research, since it may focus new therapies on the causes, not the consequences, of Huntington’s.

Research in the field has long relied on animal models, and it wasn’t until Brivanlou’s lab developed an alternative system based on human cells that they saw evidence of the disease arising during neurulation, one of the earliest stages of embryonic development. The new system, the neuroloid, is a tiny, self-organizing cell-culture colony that mimics the brain.

“It really opens a door to identifying the mechanisms that govern brain development, understanding how they go awry in disease, and testing drugs that set these mechanisms back on the right course,” says Brivanlou, who is Rockefeller’s Robert and Harriet Heilbrunn Professor.

In showing that neuroscience isn’t all about voltage, Paul Greengard electrified it
lllustration by HelloVon

Forefront

In showing that neuroscience isn’t all about voltage, Paul Greengard electrified it

lllustration by HelloVon

In 1953, the year Paul Greengard graduated as a biophysicist, scientists felt they had a pretty good idea of how the nervous system works. They saw the brain as an elaborate data-processing machine, maybe a compact version of the trailer-size IBM 650 launched that same year. Like computer chips, brain cells communicated via electrical signals, though those signals were transmitted via neural extensions and synapses rather than through copper wire. And although the brain’s apparatus was astonishingly complex, its fundamental processes were driven by plain voltage.

Neuroscience - 30nm

Data

The average distance a neurotransmitter must travel as it moves across the synapse connecting two neurons.

Greengard, however, had a hunch that things were not quite so simple. He focused instead on what he called slow synaptic transmission, a second mode of nerve-cell communication in which neurotransmitters such as dopamine or serotonin carry messages from one part of the brain to the other, ultimately producing durable changes in an organism’s mood, alertness, or sensory perception. By the early 1980s, he had shown that this chemical mode of cell-to-cell signaling actually represents the lion’s share of neuronal communication. It was work that helped jump-start modern neuroscience, and it eventually earned Greengard a Nobel Prize.

“Paul’s discoveries laid out a new paradigm,” Rockefeller’s president Richard P. Lifton said shortly after Greengard died in April, at age 93. “Today, abnormalities in signaling among neurons are recognized to underlie many disorders,” from Parkinson’s disease and schizophrenia to depression and substance abuse.

Your gut has a plan
The Rockefeller University / Laboratory of Mucosal Immunology

Forefront

Your gut has a plan

The Rockefeller University / Laboratory of Mucosal Immunology

The tens of trillions of microorganisms that inhabit the gut are, generally speaking, a friendly bunch. They help digest food, protect us from infections, and even support certain brain functions. But occasional bad actors can be found even in the best societies—and in the gut microbiota, such delinquents tend to be disease-causing food pathogens like Salmonella.

Whenever food enters the intestine, the immune system pulls off an impressive balancing act. It stays vigilant against potential arriving pathogens while at the same time keeping its cool: It tolerates the overwhelming majority of good bacteria and allows nutrients to be absorbed. Such a delicate feat calls for a good strategy—and new research shows that the gut’s immunological approach is embedded in its very topography.

In a study published in Nature, scientists in the lab of Daniel Mucida found that the gut consists of segments that pace the immune cells’ reactions to each arriving swallow. Cells capable of generating tolerance against the vast majority of luminal encounters occupy the first compartments, where nutrients are absorbed, and they are backed up by cells with better resistance capacity at the end, where invaders are eliminated.

“At first glance the intestine appears uniform throughout,” says Mucida. “But we’ve found a sophisticated functional system lurking beneath the surface.” These findings might inform the development of oral vaccines as well as drugs for gastrointestinal disorders, he says, and give scientists a finer understanding of a snack’s journey along the gastrointestinal tract.

Out of the jungle, onto the art scene
Army ants interlink their bodies to build a nest, allowing them to relocate the entire colony daily. Photograph by Daniel Kronauer

Forefront

Out of the jungle, onto the art scene

Army ants interlink their bodies to build a nest, allowing them to relocate the entire colony daily. Photograph by Daniel Kronauer

He clearly has a thing about ants. When Daniel Kronauer isn’t using them for research purposes, he stalks them with his camera, paparazzi style. “Knowing the biology of ants so well, I’m able to anticipate their behaviors and find myself in the right place at the right time,” he says.

Kronauer is head of Rockefeller’s Laboratory of Social Evolution and Behavior, and his unique photos give a ground-level view of life as an ant. His shot of a cathedral-shaped bivouac—built by and consisting of nomadic army ants in the rain forest of Costa Rica—reveals an astonishing complexity of ant teamwork. The photo earned Kronauer an award in London’s Natural History Museum’s prestigious Wildlife Photographer of the Year competition, in the invertebrate-behavior category, and is now part of an exhibit touring various international venues.

The problem with Zika
The Rockefeller University / Laboratory Of Molecular Immunology

Forefront

The problem with Zika

The Rockefeller University / Laboratory Of Molecular Immunology

For scientists working on a Zika vaccine, there’s an ugly new twist. A Rockefeller team has found that some pregnant women who’ve been infected with the virus develop antibodies that correlate with an increased risk of babies being born with microcephaly, a Zika-linked condition in which the head is underdeveloped.

“A safe vaccine would need to induce the immune system to selectively produce antibodies that are protective, avoiding those that potentially enhance the risk of microcephaly,” says Davide F. Robbiani, a research associate professor in the lab of Michel C. Nussenzweig. This means that vaccine developers must figure out not only how to make the immune system react against the virus but also how to steer its response.

Robbiani and his colleagues, who published their findings in the Journal of Experimental Medicine, discovered the problematic antibodies when analyzing blood samples from about 150 pregnant women with the virus, all collected in Brazil during the country’s 2015 Zika outbreak. Further studies in animals suggested that, rather than protecting the body from Zika, these antibodies may in fact help the virus enter maternal cells.

Stuck in a groove
Katz examines dishes of C. elegans worms. Photograph by Matthew Septimus

Forefront

Stuck in a groove

Katz examines dishes of C. elegans worms. Photograph by Matthew Septimus

For a millimeter-long roundworm with only 302 neurons, C. elegans is surprisingly curious. Constantly on the move, it inches its environment, exploring every corner and poking its head into every nook. So Menachem Katz was surprised when his roundworms stopped their leisurely stroll and instead moved frantically back and forth, like the stuck hand of a clock.

The change of routine came after Katz, a research associate in the lab of Shai Shaham, the Richard E. Salomon Family Professor, tweaked the worms’ version of astrocytes, our star-shaped brain cells known to support neurons. C. elegans has only four such cells, and Katz had taken them all out, prompting the worms into a course reversal loop. “It’s as if once they start the action, they can’t stop repeating it,” says Katz.

The idea was to see what happens when, in the absence of housekeeping astrocytes, the nervous system is unable to clear up the excess neurochemical glutamate from the junctions between neurons. In research published in Nature Communications, Katz and his team showed that the worms’ repetitive behavior is indeed caused by glutamate flooding the neurons, overstimulating them in wave after wave.

These findings mean a model organism as simple as C. elegans could be used to study the role of glutamate signaling in repetitive behaviors, opening the possibility of meaningful new experiments. In mice, for example, glutamate spillovers are linked to excessive grooming. Other studies have found mutations affecting glutamate signaling in people with obsessive-compulsive disorder and autism spectrum disorders, both of which can cause repetitive behavior. “It turns out, this model may hold up in more complex nervous systems,” Katz says.

TB and travel
Illustration by Carmen Segovia

Forefront

TB and travel

Illustration by Carmen Segovia

One in five citizens of the world hosts Mycobacterium tuberculosis, the bacterium that causes TB. If you’ve lived your whole life in the West, you’re likely not one of them, and your risk of encountering the germ in the future is extremely low.

TB and travel - Red circle 9,025

Data

The number of people who contracted tuberculosis in the United States in 2018, representing 0.09 percent of all cases worldwide.

Unless, of course, you happen to be someone who travels far and wide—to Brazil, Botswana, Bangladesh, or any of the three dozen countries where TB is rampant. In that case, your risk of contracting the disease is determined by your DNA, among other things. Some people have mutations that make them especially vulnerable to mycobacterial infection, and according to a recent study, those mutations are a lot more common than previously thought.

Earlier this year, Jean-Laurent Casanova and his team reported that one in 600 Europeans carry mutations in the gene TYK2, making their immune systems less capable of fending off the disease. It’s not a problem for those who stay in Europe, Casanova says, since “their risk of getting TB is effectively zero.” But for those with certain travel itineraries, it’s a risk factor.

Some people have mutations that make them especially vulnerable to mycobacteria, and they are more common than previously thought.

Genetic testing can reveal the mutation and may suggest when precaution is warranted. The scientists found that TYK2-associated vulnerability to TB is caused by low levels of gamma interferon, a blood protein that usually protects the body from the disease. “It’s probable that treatment with gamma interferon, a medicine that has been available for 30 years, could be an effective therapy for these people,” says Casanova, who is head of the St. Giles Laboratory of Human Genetics of Infectious Diseases.

The spermatogenesis spectacle
The Rockefeller University / Laboratory of Evolutionary Genetics and Genomics

Snapshot

The spermatogenesis spectacle

The Rockefeller University / Laboratory of Evolutionary Genetics and Genomics

The male fruit fly may be tiny, but his sperm aren’t, relatively speaking. They typically measure 1.76 millimeters—about the length of the fly himself, and 300 times longer than the sperm of Homo sapiens. As the fly’s developing sex cells travel through the twisting, blind-ended tube that constitutes its testis, each stage in their development can be traced using one marker for sperm heads (blue) and another for the rope-like tails (green).

Scientists in the lab of Li Zhao, head of the Laboratory of Evolutionary Genetics and Genomics, captured this image of a spiral-shaped Drosophila melanogaster testis during a search for de novo genes—new genes that emerge from noncoding DNA (read more in “Spermatic innovators”). The organ is a rich source of innovative genetic material, making it a superb model for research on the evolution of all living things, big or small.

Science gadget

Yeast bioreactor

Sebastian Klinge needs a lot of yeast.

Saccharomyces cerevisiae has long been a favorite model organism for cell biologists—it grows quickly and is easy to manipulate. But while many biologists get by with a smear or two, Klinge produces dozens of liters of yeast at a time. With that quantity, a flask won’t do.

Klinge is interested in the complexes that help piece together ribosomes, molecular machines that, among other useful things, manufacture the proteins that make life possible. But the molecules he’s after are both rare and fleeting; the more yeast he has, the more likely he is to find what he’s looking for.

Custom-made by a Swiss company and housed in a dedicated room just off the lab, Klinge’s bioreactor is able to grow yeast by the barrel. Similar to the equipment that microbreweries use—but carefully calibrated for precision—its tank holds up to 50 liters, and it supplies heat, air, and a precisely controlled flow of growth chemicals to optimize production.

After brewing for 72 hours, a batch of Klinge’s concoction can contain up to 700 billion cells. Each may have as many as 200,000 ribosomes—pretty good odds for catching their assembly in action.